Cargando…
m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression
Gefitinib has been widely applied for the treatment of lung adenocarcinoma (LUAD). However, the long-term application of gefitinib usually leads to acquired drug resistance in tumour patients, resulting in clinical treatment failure. Small nucleolar host gene 17 (SNHG17) has been shown to play a reg...
Autores principales: | Zhang, Heng, Wang, Shao-Qiang, Wang, Li, Lin, Hang, Zhu, Jie-Bo, Chen, Ri, Li, Lin-Feng, Cheng, Yuan-Da, Duan, Chao-Jun, Zhang, Chun-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334586/ https://www.ncbi.nlm.nih.gov/pubmed/35902569 http://dx.doi.org/10.1038/s41419-022-05050-x |
Ejemplares similares
-
METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis
por: Chu, Shaojun, et al.
Publicado: (2023) -
m(6)A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer
por: Ji, Fei, et al.
Publicado: (2021) -
The mechanism of m(6)A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene
por: Liu, Shuiping, et al.
Publicado: (2020) -
LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARγ Ubiquitination in Bladder Cancer
por: Cai, Hongzhou, et al.
Publicado: (2022) -
Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis
por: Jiang, Xiulin, et al.
Publicado: (2021)